Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1996-11-08
2000-12-12
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 71, 435372, 530300, 530350, G01H 3353
Patent
active
061597015
ABSTRACT:
Methods of treating and/or imaging tumors utilize A.sub.1 adenosine-receptor activated cells (such as monocytes and macrophages) are described. Activated cells may be administered systemically or locally, and may be radiolabelled to provide imaging and diagnostic functions. Macrophages resident in tissues may be primed and activated for use in treating and imaging tumors.
REFERENCES:
patent: 4880918 (1989-11-01), Rapaport
patent: 4904472 (1990-02-01), Belardinelli et al.
patent: 4980379 (1990-12-01), Belardinelii et al.
patent: 5049372 (1991-09-01), Rapaport
patent: 5200176 (1993-04-01), Wong et al.
Hamilton, TA. et al. 1987. Immunol. Today 8:151-158, 1987.
Salmon, JE et al. 1993. J. Immunol. 151(5):2775-2785, 1993.
BbaHacharya S. et al. 1995. BBA 1265:15-21, 1995.
Gerwin, P. et al. 1991. Mol. Pharmacol. 40:149-55, 1991.
Arya, G. et al. 1995. J. Surgical Res. 59:13-16, 1995.
Bowling, WM. et al. 1996. J. Surgical Res. 63:287-292, 1996.
Patel, A et al. 1988. Mol. Pharmacol. 33:585-591, 1988.
R.R. Aksamit et al; Inhibition of Chemotaxis by S-3-Deazaadenosylhomocysteine in a Mouse Macrophage Cell Line; The Journal of Biological Chemistry 257 No. 2, pp. 621-625 (1982).
P. Alexander and R. Evans; Endotoxin an dDouble Stranded RNA render Macrophages Cytotoxic; Nature New Biology 232, pp. 76-78 (1971).
S. Apasov et al; Role of Extracellular ATP and P1 and P2 Classes of Purinergic Receptors in T-cell Development and Cytotoxic T Lymphocyte Effector Functions; Immunological Reviews 146, pp. 5-19 (1995).
C.D. Beaty et al; Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction; Eur. J. Immunol. 24, pp. 1278-1284 (1994).
T.Y. Chen et al; Lipopolysaccharide Receptors and Signal Transduction Pathways in Mononuclear Phagocytes; Current Topics in Microbiology and Immunology 181 pp. 169-188 (1992).
S. D'Ancona et al; The Effect of Dilazep on F10 Cells in Vitro; Anticancer Research 12 pp. 631-635 (1992).
S. D'Ancona et al; Effect of Dipyridamole, 5'-(N-Ethyl)-carboxamidoadenosine and 1,3-Dipropyl-8-(2-amino-4-chlorophenyl)-xanthine on LOVO Cell Growth and Morphology; Anticancer Research 14, pp. 93-98 (1994).
A.Y. Divekar et al; Changes in Sarcoma 180 Cells Associated with Drug-induced Resistance to Adenosine Analogs.sup.1 ; Cancer Research 32, pp. 2530-2537 (Nov. 1972).
M. D. Sauro et al; Adenosine Activation of a Nuclear Pool of Protein Kinase C in Rat Splenocytes; Life Sciences 46, pp. 1293-1300 (1990).
B.A. Eppell et al; Adenosine Receptors are expressed during differentiation of monocytes to macrophages in vitro; The Journal of Immunology 143 No. 12; pp. 4141-4145 (1989).
W-G Fang et al; P.sub.2 -Purinergic Receptor Agonists Inhibit the Growth of Androgen-Independent Prostate Carcinoma Cells; The Journal of Clinical Investigation, Inc. 89, pp. 191-196 (1992).
L.M. Flebbe et al; Activation of C3H/HeJ Macrophage Tumoricidal Activity and Cytokine Release by R-Chemotype Lipopolysaccharide Preparations; The Journal of Immunology 145 No. 5; pp. 1505-1511 (1990).
K.B. Glaser et al; Bacterial Lipopolysaccharide Priming of P388D.sub.1 Macrophage-like Cells for Enhanced Arachidonic Acid Metabolism; The Journal of Biological Chemistry; 265, No. 15; pp. 8658-8664 (1990).
J.T. Grace et al; N.sup.6 -Substituted Adenine Derivatives as Growth Inhibitors of Human leukemic Myeloblasts and S-180 Cells; Abstracts Mar. 1967.
D. Lappin & K. Whaley; Adenosine A2 receptors on human monocytes modulate C2 production; Clin. exp. Immunol. 57, pp. 454-460 (1984).
H.A. Leaver et al; Phagocyte responses to endotoxin: intracellular signals and oxidative activity; FEMS Microbiology Immunology 47 pp. 293-294 (1989).
H. Loppnow et al; Induction of Cytokines in Mononuclear and Vascular Cells by Endotoxin and Other Bacterial Products; Methods in Enzymology 236, pp. 3-10 (1994).
M.R. Marvin et al; A Novel Tumor-Derived Mediator that Sensitizes Cytokine-Resistant Tumors to Tumor Necrosis Factor; Journal of Surgical Research 63, pp. 248-255 (1996).
J.E. McCormick and R. Stanley McElhinney; Nucleoside Analogues, Part 2.sup.1 Further Molecular Combinations of (5-Substituted) Uracil and N-(2-Chloroethyl)-N-nitrosoursea Residues as Anticancer Agents; Chem. Soc. Perkin Trans pp. 93-100 (1985).
C.F. Neely and I.M. Keith; A.sub.1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung; The American Physiological Society pp. 1036-1046 (1995).
C.F. Neely et al; Purinergic Responses in the Feline Pulmonary Vascular Bed; Drug Development Research 28 pp. 328-335 (1993).
C.F. Neely et al; Adenosine and ATP Produce Vasoconstriction in the Feline Pulmonary Vascular Bed by Different Mechanisms.sub.1 ; The Journal of Pharmacology and Experimental Therapeutics; 258 No. 3; pp. 753-760 (1991).
C.F. Neely and I. Matot; Pharmacological probes for A.sub.1 and A.sub.2 adenosine receptors in vivo in feline pulmonary vascular bed; The American Physiological Sciety pp. H610-619 (1996).
S. Ogawa et al; Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels; American Physiological Society pp. C546-C554 (1992).
U. Prabhakar et al; Inhibition of LPS-induced TNF.alpha. production in human monocytes by adenosine (A.sub.2) receptor selective agonists; Int. J. Immunopharmae 17 No. 3, pp. 221-224 (1995).
T. Priebe et al; Adenosine Receptors and Modulation of Natural Killer Cell Activity by Purine Nucleosides.sub.1 ; Cancer Research 50, pp. 4328-4331 (Jul. 1990).
E. Ragazzi et al; Dipyridamole as a modulator of multidrug resistance in tumour cells in vitro; International Journal of Oncology 6; pp. 659-662 (1995).
J.A. Rankin et al; Macrophages Cultured in Vitro Release Leukotriene B.sub.4 and Neutrophil Attractant/Activation Protein (Interleukin 8) Sequentially in Response to Stimulation with Lipopolysaccharide and Zymosan; The Journal of Clinical Investigation, Inc. 86, pp. 1556-1564 (1990).
F.G. Sajjadi et al; Inhibition of TNF-.alpha. Expression by Adenosine; The American Association of Immunologists pp. 3435-3442 (1996).
W.L. Salzer and C.E. McCall; Primed Stimulation of Isolated Perfused Rabbit Lung by Endotoxin and Platelet Activating Factor Induces Enhanced Production of Thromboxane and Lung Injury; Endotoxin-primed Lung Injury pp. 1135-1143 (1990).
K. Sato et al; Tolerance to the Anti-Metastatic Effect of Lipopolysaccharide Against Liver Metastasis in Mice; Int. J. Cancer 66, pp. 98-103 (1996).
A.G. Stewart and T. Harris; Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-.alpha.-induced priming of human neutrophils; Immunology 78, pp. 152-158 (1993).
D. Suk et al; Toxicological and Antiproliferative Effects of N.sup.6 -(.increment..sup.2 -Isopentenyl) adenosine, a Natural Component of Mammalian Transfer RNA.sub.1 ; Cancer Research 30, pp. 1429-1436 (May 1970).
H.B. Tey et al; Adenosine Modulates Cell Growth in Human Epidermoid Carcinoma; Biochemical and Biophysical Research Communications 187, No. 3 pp. 1486-1492; (1992).
R.Thedford et al; Cytotoxicity of N.sup.6 -Cycloalkylated Adenine and Adenosine Analogs to Mouse Hepatoma Cells; 57, pp. 53-59 (1989).
R.W. Trewyn and S.J. Kerr; Cytotoxicity of N.sup.6 -Substituted Adenosine Analogs to Cultured Trophoblastic Tumor Cells; Biochemical Pharmacology 28 pp. 607-612 (1979).
Z.Yang et al; Signal Transduction Pathways of Bacterial Lipopolysaccharide-Stimulated Bovine Vascular Endothelial Cells; Inflammation 18 No. 2; pp. 221-233 (1994).
Neely et al., A .sub.1 Adenosine Receptor Antagonists Block Ischemia-Reperfusion Injury of the Lung, American Journal Of Physiology, (Jun. 1995), vol. 268 (6 Pt 1) pp. L1036-L1046
Bowlin et al., Adeosine A .sub.3 Receptor Agonsits Inhibit Murine Macrophase Tumor Necrosis Factor .alpha. Production in Vitro and in Vivo, Cellular and Molecular Biology,May 1997, vol. 43, No. 3, 99. 345-349.
Liles et al.,Activation of Protein Kinase C Induces Rapid Internationalization and Subsequent Degradation of Muscarinic Acetylcholine Receptors in Neuroblastoma Cells, J. Biological Chemistry, Apr. 25, 1986, vol. 2
Davis Minh-Tam
Hutzell Paula K.
Link Technology Incorporated
LandOfFree
Method and compositions for treating and diagnosing tumors using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions for treating and diagnosing tumors using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for treating and diagnosing tumors using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-215453